Impaired regulation of cardiac function in sepsis, SIRS, and MODS

Canadian Journal of Physiology and Pharmacology

Volumn 87, Issue 4, 2009, Pages 266-274

  Werdan, Karl ^a   Schmidt, Hendrik ^a   Ebelt, Henning ^a   Zorn Pauly, Klaus ^b   Koidl, Bernd ^b   Hoke, Robert Sebastian ^a   Heinroth, Konstantin ^a   Müller Werdan, Ursula ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^b MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

blockers, angiotensin Converting enzyme inhibitors (acei); Autonomic dysfunction; Cardiac pacemaker current if; Endotoxin; Hcn channel; Heart rate variability (hrv); Multiorgan dysfunction syndrome (mods); Multiorgan failure (mof); Sepsis; Statins; Systemic inflammatory response syndrome (sirs)

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENDOTOXIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; HYPERPOLARIZATION ACTIVATED CYCLIC NUCLEOTIDE GATED ION CHANNEL; ION CHANNEL; NICOTINE PATCH; UNCLASSIFIED DRUG;

ACUPUNCTURE; ANTIINFLAMMATORY ACTIVITY; AUTONOMIC DYSFUNCTION; AUTONOMIC NERVOUS SYSTEM; AUTONOMIC NERVOUS SYSTEM FUNCTION; CHEMORECEPTOR REFLEX; CHOLINERGIC ACTIVITY; CLINICAL TRIAL; CORONARY ARTERY DISEASE; ELECTRIC CURRENT; HEART FAILURE; HEART FUNCTION; HEART INNERVATION; HEART RATE VARIABILITY; HUMAN; MULTIPLE ORGAN FAILURE; PACEMAKER NERVE CELL; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SEPSIS; SEPTIC SHOCK; SINUS NODE; SURVIVAL RATE; SYMPATHETIC TONE; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TREATMENT OUTCOME; VAGUS NERVE STIMULATION; VAGUS TONE;

ADRENERGIC BETA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; HEART; HEART RATE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MULTIPLE ORGAN FAILURE; PROGNOSIS; SEPSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; VAGUS NERVE;

EID: 65249101633     PISSN: 00084212     EISSN: None     Source Type: Journal    
DOI: 10.1139/Y09-012     Document Type: Review

References (48)

1. Agostoni, P., Contini, M., Magini, A., Apostolo, A., Cattadori, G., Bussotti, M., et al. 2006. Carvedilol reduces exercise-induced hyperventilation: A benefit in normoxia and a problem with hypoxia. Eur. J. Heart Fail. 8(7): 729-735. doi:10.1016/j.ejheart. 2006.02.001. PMID:16533619.
2. Almog, Y., Shefer, A., Novack, V., Maimon, N., Barski, L., Eizin- ger, M., et al. 2004. Prior statin therapy is associated with a decreased rate of severe sepsis. Circulation, 110(7): 880-885. doi:10.1161/01.CIR. 0000138932.17956.F1. PMID:15289367.
3. Baruscotti, M., Bucchi, A., and Difrancesco, D. 2005. Physiology and pharmacology of the cardiac pacemaker ("funny") current. Pharmacol. Ther. 107(1): 59-79. doi:10.1016/j.pharmthera.2005. 01.005. PMID:15963351.
4. Biel, M., Schneider, A., and Wahl, C. 2002. Cardiac HCN channels: structure, function, and modulation. Trends Cardiovasc. Med. 12(5): 206-212. doi:10.1016/S1050-1738(02)00162-7. PMID:12161074.
5. Borovikova, L.V., Ivanova, S., Zhang, M., Yang, H., Botchkina, G.I., Watkins, L.R., et al. 2000. Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature, 405(6785): 458-162. doi:10.1038/35013070. PMID:10839541.
6. Calvin, J.E., Driedger, A.A., and Sibbald, W.J. 1981. An assessment of myocardial function in human sepsis utilizing ECG gated cardiac scintigraphy. Chest, 80(5): 579-586. doi:10.1378/ chest.80.5.579. PMID:7297149.
7. CONSENSUS Trial Study Group. 1987. Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N. Engl. J. Med. 316(23): 1429-1435. PMID:2883575.
8. Engel, C., Brunkhorst, F.M., Bone, H.G., Brunkhorst, R., Gerlach, H., Grond, S., et al. 2007. Epidemiology of sepsis in Germany: results from a national prospective multicenter study. Intensive Care Med. 33(4): 606-618. doi:10.1007/s00134-006-0517-7. PMID:17323051.
9. Ferrario, C.M., and Strawn, W.B. 2006. Role of the renin- angiotensin-aldosterone system and proinflammatory mediators in cardiovascular disease. Am. J. Cardiol. 98(1): 121-128. doi:10.1016/j.amjcard.2006.01. 059. PMID:16784934.
10. Godin, P.J., and Buchman, T.G. 1996. Uncoupling of biological oscillators: a complementary hypothesis concerning the pathogen- esis of multiple organ dysfunction syndrome. Crit. Care Med. 24(7): 1107-1116. doi:10.1097/00003246-199607000-00008. PMID:8674321.
11. Godin, P.J., Fleisher, L.A., Eidsath, A., Vandivier, R.W., Preas, H.L., Banks, S.M., et al. 1996. Experimental human endotoxe- mia increases cardiac regularity: results from a prospective, randomized, crossover trial. Crit. Care Med. 24(7): 1117-1124. doi:10.1097/00003246-199607000-00009. PMID:8674322.
12. Heinroth, K.M., Kuhn, C., Stache, N., Witthaut, R., Müller-Wer- dan, U., Werdan, K., and Prondzinsky, R. 1999. Reduced heart rate variability in patients with septic and non-septic multiorgan dysfunction syndrome. Intensivmed. Notfallmed. 36: 436-445. doi:10.1007/s003900050262.
13. Jafri, S.M., Lavine, S., Field, B.E., Bahorozian, M.T., and Carlson, R.W. 1990. Left ventricular diastolic function in sepsis. Crit. Care Med. 18(7): 709-714. doi:10.1097/00003246-199007000- 00005. PMID:2364710.
14. Kruger, P., Fitzsimmons, K., Cook, D., Jones, M., and Nimmo, G. 2006. Statin therapy is associated with fewer deaths in patients with bacteraemia. Intensive Care Med. 32(1): 75-79. doi:10.1007/s00134-005-2859-y. PMID:16283159.
15. Kurata, Y., Hisatome, I., Imanishi, S., and Shibamoto, T. 2002. Dynamical description of sinoatrial node pacemaking: improved mathematical model for primary pacemaker cell. Am. J. Physiol. Heart Circ. Physiol. 283(5): H2074-H2101. PMID:12384487.
16. Li, Y.L., Xia, X.H., Zheng, H., Gao, L., Li, Y.F., Liu, D., et al. 2006. Angiotensin II enhances carotid body chemoreflex control of sympathetic outflow in chronic heart failure rabbits. Cardio- vasc. Res. 71(1): 129-138. doi:10.1016/j.cardiores.2006.03.017. PMID:16650840.
17. Libert, C. 2003. Inflammation: A nervous connection. Nature, 421(6921): 328-329. doi:10.1038/421328a. PMID:12540886.
18. Ludwig, A., Zong, X., Jeglitsch, M., Hofmann, F., and Biel, M. 1998. A family of hyperpolarization- activated mammalian cation channels. Nature, 393(6685): 587-591. doi:10.1038/31255. PMID:9634236.
19. Ludwig, A., Zong, X., Hofmann, F., and Biel, M. 1999. Structure and function of cardiac pacemaker channels. Cell. Physiol. Bio- chem. 9(4-5): 179-186. doi:10.1159/000016315. PMID: 10575196.
20. Merx, M.W., and Weber, C. 2007. Sepsis and the heart. Circulation, 116(7): 793-802. doi:10.1161/CIRCULATIONAHA.106. 678359. PMID:17698745.
21. Merx, M.W., Liehn, E.A., Janssens, U., Lutticken, R., Schrader, J., Hanrath, P., et al. 2004. HMG-CoA reductase inhibitor simvastatin profoundly improves survival in a murine model of sepsis. Circulation, 109(21): 2560-2565. doi:10.1161/01.CIR. 0000129774.09737.5B. PMID:15123521.
22. Müller-Werdan, U., Reithmann, C., and Werdan, K. 1996. Cytokines and the heart: molecular mechanisms of septic cardiomyo- pathy. Springer, Berlin.
23. Müller-Werdan, U., Buerke, M., Ebelt, H., Heinroth, K.M., Herk- lotz, A., Loppnow, H., et al. 2006. Septic cardiomyopathy: a not yet discovered cardiomyopathy? Exp Clin Cardiol, 11(3): 226-236. PMID:18651035.
24. Munt, B., Jue, J., Gin, K., Fenwick, J., and Tweeddale, M. 1998. Diastolic filling in human severe sepsis: an echocardiographic study. Crit. Care Med. 26(11): 1829-1833. PMID:9824075.
25. Parati, G., Mutti, E., Frattola, A., Castiglioni, P., di Rienzo, M., and Mancia, G. 1994. Beta-adrenergic blocking treatment and 24-hour baroreflex sensitivity in essential hypertensive patients. Hypertension, 23(6 Pt 2): 992-996. PMID:7911452.
26. Parker, M.M., Shelhamer, J.H., Bacharach, S.L., Green, M.V., Na- tanson, C., Frederick, T.M., et al. 1984. Profound but reversible myocardial depression in patients with septic shock. Ann. Intern. Med. 100(4): 483-490. PMID:6703540.
27. Parrillo, J.E. 1989. The cardiovascular pathophysiology of sepsis. Annu. Rev. Med. 40: 469-485. PMID:2658761.
28. Parrillo, J.E., Parker, M.M., Natanson, C., Suffredini, A.F., Danner, R.L., Cunnion, R.E., et al. 1990. Septic shock in humans. Advances in the understanding of pathogenesis, cardiovascular dysfunction, and therapy. Ann. Intern. Med. 113(3): 227-242. PMID:2197912.
29. Pavlov, V.A., Ochani, M., Gallowitsch-Puerta, M., Ochani, K., Huston, J.M., Czura, C.J., et al. 2006. Central muscarinic cholinergic regulation of the systemic inflammatory response during endotoxemia. Proc. Natl. Acad. Sci. U.S.A. 103(13): 5219-5223. doi:10.1073/pnas.0600506103. PMID:16549778.
30. Poelaert, J., Declerck, C., Vogelaers, D., Colardyn, F., and Visser, C.A. 1997. Left ventricular systolic and diastolic function in septic shock. Intensive Care Med. 23(5): 553-560. doi:10.1007/ s001340050372. PMID:9201528.
31. Pruefer, D., Makowski, J., Schnell, M., Buerke, U., Dahm, M., Oe- lert, H., et al. 2002. Simvastatin inhibits inflammatory properties of Staphylococcus aureus alpha-toxin. Circulation, 106(16):2104-2110. doi:10.1161/01.CIR. 0000034048.38910.91. PMID: 12379581.
32. Ren, J., Ren, B.H., and Sharma, A.C. 2002. Sepsis-induced depressed contractile function of isolated ventricular myocytes is due to altered calcium transient properties. Shock, 18(3): 285-288. doi:10.1097/00024382- 200209000-00014. PMID:12353932.
33. Routledge, H.C., Chowdhary, S., and Townend, J.N. 2002. Heart rate variability: a therapeutic target? J. Clin. Pharm. Ther. 27(2): 85-92. doi:10.1046/j.1365-2710.2002.00404.x. PMID:11975691.
34. Saeed, R.W., Varma, S., Peng-Nemeroff, T., Sherry, B., Balakha- neh, D., Huston, J., et al. 2005. Cholinergic stimulation blocks endothelial cell activation and leukocyte recruitment during inflammation. J. Exp. Med. 201(7): 1113-1123. doi:10.1084/jem. 20040463. PMID:15809354.
35. Schmidt, H., Muller-Werdan, U., Nuding, S., Hoffmann, T., Francis, D.P., Hoyer, D., et al. 2004. Impaired chemoreflex sensitivity in adult patients with multiple organ dysfunction syndrome: the potential role of disease severity. Intensive Care Med. 30(4): 665-672. doi:10.1007/s00134-003-2131-2. PMID: 14963644.
36. Schmidt, H., Miiller-Werdan, U., Hoffmann, T., Francis, D.P., Pie- poli, M.F., Rauchhaus, M., et al. 2005. Autonomic dysfunction predicts mortality in patients with multiple organ dysfunction syndrome of different age groups. Crit. Care Med. 33(9): 1994-2002. doi:10.1097/01.CCM.0000178181.91250.99. PMID:16148471.
37. Schmidt, H., Hennen, R., Keller, A., Russ, M., Muller- Werdan, U., Werdan, K., et al. 2006. Association of statin therapy and increased survival in patients with multiple organ dysfunction syndrome. Intensive Care Med. 32(8): 1248-1251. doi:10.1007/s00134-006-0246-y. PMID:16788803.
38. Schmidt, H., Saworski, J., Werdan, K., and Miiller- Werdan, U. 2007. Decreased beating rate variability of spontaneously contracting cardiomyocytes after co-incubation with endotoxin. J. Endotoxin Res. 13(6): 339-342. doi:10.1177/0968051907086233. PMID:18182461.
39. Schmidt, H., Hoyer, D., Hennen, R., Heinroth, K., Rauchhaus, M., Prondzinsky, R., et al. 2008a. Autonomic dysfunction predicts both 1- and 2-month mortality in middle-aged patients with multiple organ dysfunction syndrome. Crit. Care Med. 36(3): 967-970. PMID:18431287.
40. Schmidt, H., Muller-Werdan, U., and Werdan, K. (2008b). The consequences of cardiac autonomic dysfunction in multiple organ dysfunction syndrome. In Yearbook of Intensive Care Medicine. Edited by J.L. Vincent. Springer, New York. pp. 55-64.
41. SOLVD Investigators. 1991. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N. Engl. J. Med. 325(5): 293-302. PMID: 2057034.
42. Tracey, K.J. 2002. The inflammatory reflex. Nature, 420(6917):853- 859. doi:10.1038/nature01321. PMID:12490958.
43. Tracey, K.J. 2007. Physiology and immunology of the cholinergic antiinflammatory pathway. J. Clin. Invest. 117(2): 289-296.doi:10.1172/ JCI30555. PMID:17273548.
44. Vincent, J.L., Sakr, Y., Sprung, C.L., Ranieri, V.M., Reinhart, K., Gerlach, H., et al. 2006. Sepsis in European intensive care units:results of the SOAP study. Crit. Care Med. 34(2): 344-353. doi:10.1097/01.CCM. 0000194725.48928.3A. PMID:16424713.
45. Wang, H., Yu, M., Ochani, M., Amella, C.A., Tanovic, M., Sus- arla, S., et al. 2003. Nicotinic acetylcholine receptor alpha7 sub- unit is an essential regulator of inflammation. Nature, 421(6921): 384-388. doi:10.1038/nature01339. PMID:12508119.
46. Wang, H., Liao, H., Ochani, M., Justiniani, M., Lin, X., Yang, L., et al. 2004. Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis. Nat. Med. 10(11): 1216-1221. doi:10.1038/nm1124. PMID:15502843.
47. Welzig, C.M., Shin, D.G., Park, H.J., Kim, Y.J., Saul, J.P., and Galper, J.B. 2003. Lipid lowering by pravastatin increases para- sympathetic modulation of heart rate: Galpha(i2), a possible molecular marker for parasympathetic responsiveness. Circulation, 108(22): 2743-2746. doi:10.1161/01.CIR. 0000103680.61390.16. PMID:14623802.
48. Zorn- Pauly, K., Pelzmann, B., Lang, P., Machler, H., Schmidt, H., Ebelt, H., et al. 2007. Endotoxin impairs the human pacemaker current If. Shock, 28(6): 655-661. PMID:18092381.